Cargando…
MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma
In recent years, increasing studies demonstrated that miR-145 plays a tumor suppressor role in many human cancers. In the present study, we evaluated the expression of miR-145 and A Disintegrin and Metalloproteinase 19 (ADAM19) in glioblastoma multiforme (GBM) tissues and cells. Furthermore, we inve...
Autores principales: | Wang, Xingqiang, Wang, Enqin, Cao, Jun, Xiong, Feng, Yang, Yonglin, Liu, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696202/ https://www.ncbi.nlm.nih.gov/pubmed/29190936 http://dx.doi.org/10.18632/oncotarget.21442 |
Ejemplares similares
-
MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma
por: Chen, Weijie, et al.
Publicado: (2019) -
ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression
por: Yang, Jen-Tsung, et al.
Publicado: (2023) -
MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2012) -
Retraction: MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2013) -
The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma
por: Wang, Xingqiang, et al.
Publicado: (2017)